Juliet S. Jones, Ph.D. - Publications
Affiliations: | 2002 | University of Texas Medical Branch, Galveston, TX |
Area:
Pharmacology, Toxicology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Elshafei A, Chevli KK, Moussa AS, Kara O, Chueh SC, Walter P, Hatem A, Gao T, Jones JS, Duff M. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy. The Prostate. PMID 26384170 DOI: 10.1002/pros.23096 | 0.304 | |||
2015 | Chen DJ, Falzarano SM, McKenney JK, Przybycin CG, Reynolds JP, Roma A, Jones JS, Stephenson A, Klein E, Magi-Galluzzi C. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance? Bju International. 116: 220-9. PMID 25060664 DOI: 10.1111/bju.12880 | 0.319 | |||
2013 | Sverrisson E, Jones JS, Pow-Sang JM. [Cryosurgery for prostate cancer: a comprehensive review]. Archivos EspañOles De UrologíA. 66: 546-56. PMID 23985454 | 0.303 | |||
2011 | Lee MC, Moussa AS, Zaytoun O, Yu C, Jones JS. Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia. Urology. 78: 1115-9. PMID 22054382 DOI: 10.1016/j.urology.2011.04.067 | 0.304 | |||
Show low-probability matches. |